SLC2A1 and relapsing-remitting multiple sclerosis: CD28 autonomous stimulation up-regulated Glut1 expression in CD4+ T cells in RRMS patients (Figure S3b), at higher levels than HD (Figure S3c) and, in particular, on the inflammatory Th17 cell subset (Figure S3d,e).